N
JAZZ icon

Numerai’s Jazz Pharmaceuticals JAZZ Stock Holding History

Numerai’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
19,930
+5,946
+43% +$1.3M 0.39% 47
2026
Q1 		$2.64M Buy
+13,984
New +$2.44M 0.27% 99
2025
Q2 		– Sell
-7,523
Closed -$934K – 547
2025
Q1 		$934K Buy
+7,523
New +$981K 0.18% 173

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Numerai's JAZZ Position: Q2 2026 in Review

Numerai increased its Jazz Pharmaceuticals (JAZZ) stake by 43% in Q2 2026, buying an estimated $1.3M and bringing the position to 19,930 shares worth $4.8M. The position accounts for 0.39% of the portfolio, ranked #47.

Numerai first reported a position in JAZZ in Q1 2025 and has held it in 3 quarters since. 645 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Numerai held 19,930 shares of Jazz Pharmaceuticals worth $4.8M as of Q2 2026.
  • Numerai bought 5,946 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.3M.
  • Jazz Pharmaceuticals made up 0.39% of Numerai's portfolio in Q2 2026, its #47 holding.
  • Numerai first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 645 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.